TMO

Thermo Fisher Scientific
D

TMO

Arincen67/100B

Thermo Fisher Scientific cash on hand 1985–2026

Thermo Fisher Scientific had 6.06B USD in cash and short-term investments on 26 September 2026, up 70.9% on a year before. At the end of fiscal year 2025 it had 10.11B USD.

Last updated 3 Nov 2026 · Next report 4 Feb 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter26 Sept 20266.06B+70.92%41.37B-35.31B
FY202531 Dec 202510.11B+81.09%39.39B-29.28B
FY202431 Dec 20245.58B-30.97%32.78B-27.20B
FY202331 Dec 20238.08B-5.17%36.42B-28.34B
FY202231 Dec 20228.52B+90.40%36.07B-27.55B
FY202131 Dec 20214.48B-56.64%36.34B-31.86B
FY202031 Dec 202010.33B+330.39%22.55B-12.22B
FY201931 Dec 20192.40B+14.08%18.49B-16.09B
FY201831 Dec 20182.10B+57.53%18.99B-16.89B
FY201731 Dec 20171.34B+69.85%21.01B-19.67B
FY201631 Dec 2016786.00M+73.86%16.63B-15.84B
FY201531 Dec 2015452.10M-66.35%12.47B-12.02B
FY201431 Dec 20141.34B-76.97%14.56B-13.22B
FY201331 Dec 20135.83B+620.37%10.49B-4.65B
FY201231 Dec 2012809.90M-20.64%7.12B-6.31B
FY201131 Dec 20111.02B+10.22%7.03B-6.01B
FY201031 Dec 2010926.00M-41.06%2.17B-1.24B
FY200931 Dec 20091.57B+21.99%2.18B-612.20M
FY200831 Dec 20081.29B+101.50%2.06B-770.30M
FY200731 Dec 2007639.20M-10.68%2.20B-1.56B
FY200631 Dec 2006715.60M+142.59%2.66B-1.95B
FY200531 Dec 2005294.99M-42.41%598.77M-303.78M
FY200431 Dec 2004512.26M+22.48%241.09M271.17M
FY200331 Dec 2003418.24M-52.23%275.49M142.75M
FY200231 Dec 2002875.47M-15.98%935.82M-60.35M
FY200131 Dec 20011.04B+1.46%787.00M255.00M
FY200031 Dec 20001.03B+22.55%1.61B-582.00M
FY199931 Dec 1999838.00M-45.87%1.68B-841.00M
FY199831 Dec 19981.55B+1.64%2.16B-612.00M
FY199731 Dec 19971.52B-17.50%1.92B-397.00M
FY199631 Dec 19961.85B+74.81%1.70B142.00M
FY199531 Dec 19951.06B+175.86%1.22B-166.00M
FY199431 Dec 1994382.80M+17.53%1.13B-750.00M
FY199331 Dec 1993325.70M+70.88%693.40M-367.70M
FY199231 Dec 1992190.60M+45.50%516.20M-325.60M
FY199131 Dec 1991131.00M+11.11%259.90M-128.90M
FY199031 Dec 1990117.90M+25.56%216.80M-98.90M
FY198931 Dec 198993.90M-31.16%199.60M-105.70M
FY198831 Dec 1988136.40M-5.34%159.80M-23.40M
FY198731 Dec 1987144.10M+125.86%141.00M3.10M
FY198631 Dec 198663.80M+112.67%62.90M900.00K
FY198531 Dec 198530.00M—51.00M-21.00M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet

Common questions about Thermo Fisher Scientific's cash

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.